Learn More
Description
- Lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly in anterior nasal swab specimens from individuals with signs and symptoms of respiratory tract infection
- QC Inside: Two extra test devices have been included for external QC testing
Specifications
Specifications
| CE Marker | No |
| Clia Complexity | Waived |
| Detectable Analytes | SARS-CoV-2, Influenza A, Influenza B |
| Type | Combo Test |
| Disposable | Single-use |
| Form | Swab |
For prescription use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.